PXMD

PAXMEDICA INC by PaxMedica, Inc. (PXMD)

About PAXMEDICA INC by PaxMedica, Inc. (PXMD)

PaxMedica, Inc. is a clinical stage biopharmaceutical company. It engages in the business of developing drug candidates for the treatment of autism spectrum disorder, Fragile X syndrome tremor-ataxia, and Human African Trypanosomiasis. The company was founded by Michael L. Derby on April 5, 2018 and is headquartered in Tarrytown, NY.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.78
52 Week Low
$0.00
Market cap
1,100
Dividend yield
0.00%
Volume
--
Avg. volume
3,185
P/E ratio
.00

PAXMEDICA INC by PaxMedica, Inc. News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.78
52 Week Low
$0.00
Market cap
1,100
Dividend yield
0.00%
Volume
--
Avg. volume
3,185
P/E ratio
.00